Galenica AG

0ROG · LSE

91.40GBP+0.60 (+0.66%)

Price History

Full chart

Market Stats

Previous Close90.80

Open91.40

Day Range91.05 – 91.40

52-Week Range80.45 – 102.99

Volume1.11K

Market Cap4.17B

P/E (TTM)0.24

Forward P/E0.00

EPS3.38

Dividend Yield0.01%

Beta0.28

50-Day Avg75.53

200-Day Avg71.40

About

Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients at home; laboratory medicine, pathology and specialized personalized diagnostic services; and develops, markets, and sells healthcare services and products through various distribution channels. The Logistics & IT segment provides various specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers master data systems for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as offers complete management solutions for pharmacies. In addition, it provides on-schedule delivery services to pharmacies, drugstores, doctors, hospitals, and care homes. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Company Details

CEOMr. Marc Werner
Employees6.62K
HeadquartersUntermattweg 8, Bern, Switzerland, 3027, UK
Websitehttps://www.galenica.com

Leadership

Mr. Marc WernerChief Executive Officer · b. 1967
Mr. Julian FiessingerChief Financial Officer · b. 1982
Ms. Cécile MatterGroup General Counsel · b. 1984
Ms. Iris MullerChief Communications Officer · b. 1983
Ms. Arianne HaslerChief People & Culture · b. 1979
Dr. Jörg KneubühlerAdvisor · b. 1960
Dr. Thomas F. SzuranChief of Products & Home Care & Deputy CEO of Galenica Group · b. 1967
Mr. Daniele MadonnaChief of Pharmacies Category Management & Health Services · b. 1977
Mr. Andreas KochChief of Wholesale & Logistics · b. 1971
Ms. Virginie Pache JeschkaChief of Pharmacies Sales · b. 1979

Financials

Income Statement

Currency: GBP	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	2.83B	2.92B	3.01B	3.14B	3.17B	3.30B	3.48B	3.83B	3.59B	3.76B	3.92B	4.14B
Growth (%)	-	+3.15%	+3.11%	+4.40%	+0.76%	+4.30%	+5.42%	+10.20%	-6.42%	+4.67%	+4.39%	+5.47%
Cost of Revenue	2.53B	2.61B	2.72B	2.85B	2.89B	3.00B	3.13B	3.48B	3.23B	3.29B	3.53B	3.71B
Gross Profit	301.05M	312.28M	286.38M	292.40M	276.57M	297.82M	349.41M	350.55M	360.04M	461.34M	394.83M	428.80M
Gross Margin	10.64%	10.70%	9.52%	9.31%	8.74%	9.02%	10.04%	9.14%	10.03%	12.28%	10.07%	10.37%
Operating Expense	191.75M	197.09M	209.58M	172.10M	177.13M	142.17M	147.16M	164.22M	177.43M	18.08M	193.40M	206.03M
Operating Income	109.30M	115.18M	76.80M	120.30M	99.44M	155.65M	202.25M	186.33M	182.62M	443.27M	201.43M	222.78M
Operating Margin	3.86%	3.95%	2.55%	3.83%	3.14%	4.72%	5.81%	4.86%	5.09%	11.80%	5.14%	5.39%
EBITDA	143.57M	149.34M	160.05M	165.18M	147.70M	254.69M	302.78M	300.33M	290.46M	229.13M	331.31M	339.18M
EBITDA Margin	5.07%	5.12%	5.32%	5.26%	4.67%	7.72%	8.70%	7.83%	8.09%	6.10%	8.45%	8.20%
Net Income	81.82M	81.12M	83.39M	118.80M	147.55M	124.99M	172.25M	167.68M	165.13M	173.60M	182.95M	181.10M
Net Income Margin	2.89%	2.78%	2.77%	3.78%	4.66%	3.79%	4.95%	4.37%	4.60%	4.62%	4.67%	4.38%
R&D	13.98M	14.07M	12.20M	10.90M	11.90M	13.40M	15.70M	15.20M	13.50M	12.70M	14.00M	8.30M
R&D as % of Total Revenue	0.49%	0.48%	0.41%	0.35%	0.38%	0.41%	0.45%	0.40%	0.38%	0.34%	0.36%	0.20%
Interest Expense	18.23M	20.29M	19.81M	2.74M	2.80M	6.18M	5.25M	5.66M	5.47M	15.81M	13.15M	15.64M
Interest Expense % of Total Revenue	0.64%	0.70%	0.66%	0.09%	0.09%	0.19%	0.15%	0.15%	0.15%	0.42%	0.34%	0.38%

Balance Sheet

Currency: GBP	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.73B	1.71B	1.73B	1.99B	1.80B	1.86B	2.21B	2.26B	2.62B	2.66B	2.99B	3.12B	3.34B
Total Liabilities	1.51B	1.47B	1.47B	1.65B	936.67M	926.49M	1.21B	1.21B	1.38B	1.41B	1.52B	1.57B	1.86B
Total Equity	209.73M	230.30M	254.04M	329.62M	857.28M	929.46M	993.50M	1.05B	1.23B	1.25B	1.47B	1.55B	1.48B
Cash	18.62M	22.27M	10.50M	9.02M	96.29M	104.97M	90.53M	59.78M	164.98M	93.93M	116.16M	129.68M	115.51M
Total Debt	917.19M	919.21M	897.73M	1.11B	406.29M	410.58M	656.07M	640.63M	672.65M	686.49M	725.90M	833.98M	1.06B
Net Debt	898.57M	896.94M	887.23M	1.10B	310.00M	305.61M	565.54M	580.85M	507.67M	592.56M	609.74M	704.30M	945.46M

Cash Flow

Currency: CHF	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	84.12M	132.44M	156.82M	144.40M	173.55M	250.44M	224.36M	333.10M	236.87M	225.71M	264.70M	299.76M
Investing Cash Flow	-53.62M	-55.77M	-64.32M	-45.73M	-87.64M	-134.89M	-115.84M	-88.34M	-130.62M	-124.17M	-151.57M	-333.14M
Financing Cash Flow	-26.84M	-88.42M	-93.97M	-11.40M	-77.22M	-129.98M	-139.30M	-139.53M	-177.21M	-79.05M	-99.74M	19.20M
Capital Expenditure	34.54M	37.89M	34.94M	54.03M	47.45M	53.59M	55.69M	60.07M	69.80M	44.54M	37.01M	27.41M
Free Cash Flow	49.58M	94.55M	121.87M	90.37M	126.10M	196.85M	168.67M	273.02M	167.07M	181.17M	227.69M	272.35M
Dividends Paid	54.05M	46.00M	46.00M	766.93M	81.03M	83.76M	89.15M	89.20M	104.44M	110.27M	110.17M	115.11M
FCF to OCF	58.94%	71.39%	77.72%	62.58%	72.66%	78.60%	75.18%	81.97%	70.53%	80.27%	86.02%	90.86%
Dividend Paid to FCF	109.01%	48.65%	37.74%	848.68%	64.26%	42.55%	52.86%	32.67%	62.51%	60.86%	48.39%	42.27%

Earnings

Report Date	Mar 9, 2027
EPS Estimate	-
EPS Actual	-
Surprise	-
Timing	Pre-market

Key Statistics & Ratios

Market Cap4.17B

Enterprise Value5.18B

Trailing P/E0.24

Forward P/E0.00

Price / Sales1.01

Price / Book0.00

EPS3.38

Book Value28.30

Revenue (TTM)4.29B

Gross Profit (TTM)534.00M

EBITDA255.69M

Profit Margin3.72%

Operating Margin3.89%

Return on Equity11.36%

Return on Assets4.00%

Shares Outstanding49.06M

Shares Float49.74M

Beta0.28

Dividend Yield0.01%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20261×

0.01Apr 23, 2026

20251×

0.01Apr 14, 2025

20241×

0.01Apr 12, 2024

20231×

0.01May 5, 2023

20221×

0.01May 13, 2022

20211×

0.01May 17, 2021

20201×

0.01May 22, 2020

20191×

0.02May 6, 2019

20181×

0.02May 14, 2018